|
Association of Tau and Neuronal Hypometabolism with Positron Emission Tomography in Alzheimers Disease |
1F30AG074524-01A1 |
|
NIA |
2022 |
|
Effects of metabolic phenotype on functional connectivity in aging and Alzheimer’s Disease |
1F30AG076278-01 |
|
NIA |
2022 |
|
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimers Disease |
1F30AG077736-01 |
|
NIA |
2022 |
|
Multimodal, multiclass prediction of disease status in Alzheimer’s |
1F30AG079610-01 |
|
NIA |
2022 |
|
AMPK localization, expression, and activity in Alzheimers Disease |
1F30AG079633-01 |
|
NIA |
2022 |
|
Explaining racial and ethnic Alzheimer’s disease disparities with joint estimation of life course social inequities and measurement bias in verbal memory assessment |
1F31AG076284-01 |
|
NIA |
2022 |
|
Single-cell epigenomic roadmap of Alzheimers disease |
1F31AG076308-01 |
|
NIA |
2022 |
|
Pathologic Substrates of Neuropsychiatric Symptoms in Aphasic Dementia |
1F31AG076318-01 |
|
NIA |
2022 |
|
Development of Novel Synthetic Proteomimetics for Mediating Tauopathy in Alzheimers Disease |
1F31AG076334-01 |
|
NIA |
2022 |
|
The combinatorial effects of familial mutations, oxidative stress, and aging on BBB dysfunction in Alzheimers disease |
1F31AG077930-01 |
|
NIA |
2022 |